[HTML][HTML] Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis

J Wang, K Hu, X Cai, B Yang, Q He, J Wang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial pneumonia
with unknown causes. The incidence rate increases year by year and the prognosis is poor …

[HTML][HTML] Inflammation and immunity in IPF pathogenesis and treatment

P Heukels, CC Moor, JH Von der Thüsen… - Respiratory …, 2019 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive, and ultimately fatal, chronic interstitial
lung disease characterized by enhanced extracellular matrix deposition. Repetitive alveolar …

Immune mechanisms in pulmonary fibrosis

S Kolahian, IE Fernandez, O Eickelberg… - American journal of …, 2016 - atsjournals.org
Pulmonary fibrosis, particularly idiopathic pulmonary fibrosis, represents a chronic and
progressive disease with high mortality and limited therapeutic options. Excessive …

Molecular and cellular mechanisms of pulmonary fibrosis

NW Todd, IG Luzina, SP Atamas - Fibrogenesis & tissue repair, 2012 - Springer
Pulmonary fibrosis is a chronic lung disease characterized by excessive accumulation of
extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary …

The transcription factor NRF2 protects against pulmonary fibrosis

HY Cho, SPM Reddy, M Yamamoto… - The FASEB …, 2004 - Wiley Online Library
The molecular mechanisms of pulmonary fibrosis are poorly understood, although reactive
oxygen species are thought to have an important role. NRF2 is a transcription factor that …

Implications of the immune landscape in COPD and lung cancer: smoking versus other causes

E Taucher, I Mykoliuk, J Lindenmann… - Frontiers in …, 2022 - frontiersin.org
Cigarette smoking is reported in about one third of adults worldwide. A strong relationship
between cigarette smoke exposure and chronic obstructive pulmonary disease (COPD) as …

The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases

PJ Wermuth, SA Jimenez - Clinical and translational medicine, 2015 - Springer
The systemic and organ-specific human fibrotic disorders collectively represent one of the
most serious health problems world-wide causing a large proportion of the total world …

Dual roles of IL-4 in lung injury and fibrosis

F Huaux, T Liu, B McGarry, M Ullenbruch… - The Journal of …, 2003 - journals.aai.org
Increased lung IL-4 expression in pulmonary fibrosis suggests a potential pathogenetic role
for this cytokine. To dissect this role, bleomycin-induced pulmonary inflammation and …

Multiple fibroblast subtypes contribute to matrix deposition in pulmonary fibrosis

X Liu, K Dai, X Zhang, G Huang, H Lynn… - American Journal of …, 2023 - atsjournals.org
Progressive pulmonary fibrosis results from a dysfunctional tissue repair response and is
characterized by fibroblast proliferation, activation, and invasion and extracellular matrix …

Pulmonary toxicity of silica linked to its micro-or nanometric particle size and crystal structure: A review

V Marques Da Silva, M Benjdir, P Montagne, JC Pairon… - Nanomaterials, 2022 - mdpi.com
Silicon dioxide (SiO2) is a mineral compound present in the Earth's crust in two mineral
forms: crystalline and amorphous. Based on epidemiological and/or biological evidence, the …